Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function
Inflammatory bowel disease is a chronic inflammatory disorder occurring in the gastrointestinal track. However, the efficacy of current therapeutic strategies has been limited and accompanied by side effects. In order to eliminate the limitations, herbal medicines have recently been developed for tr...
Saved in:
Published in | Laboratory animal research Vol. 32; no. 3; pp. 151 - 159 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
01.09.2016
Korean Association for Laboratory Animal Science BMC 한국실험동물학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-6055 2233-7660 |
DOI | 10.5625/lar.2016.32.3.151 |
Cover
Summary: | Inflammatory bowel disease is a chronic inflammatory disorder occurring in the gastrointestinal track. However, the efficacy of current therapeutic strategies has been limited and accompanied by side effects. In order to eliminate the limitations, herbal medicines have recently been developed for treatment of IBD.
Peuraria Lobata
(
Peuraria L.
) is one of the traditional herbal medicines that have anti-inflammatory effects. Bioavailability of
Peuraria L.
, which is rich in isoflavones, is lower than that of their fermented forms. In this study, we generated fermented
Peuraria L.
extracts (fPue) and investigated the role of fPue in inflammation and intestinal barrier function
in vitro
and
in vivo
. As the mice or intestinal epithelial cells were treated with DSS/fPue, mRNA expression of pro-inflammatory cytokines was reduced and the architecture and expression of tight junction proteins were recovered, compared to the DSS-treated group. In summary, fPue treatment resulted in amelioration of DSS-induced inflammation in the colon, and the disrupted intestinal barrier was recovered as the expression and architecture of tight junction proteins were retrieved. These results suggest that use of fPue could be a new therapeutic strategy for treatment of IBD. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001509.2016.32.3.006 |
ISSN: | 1738-6055 2233-7660 |
DOI: | 10.5625/lar.2016.32.3.151 |